Home > Patients > Patient Questions and Glossary

Patient Questions and Glossary

NovaDigm just completed a Phase 1a/2b clinical trial of the NDV-3A vaccine in patients diagnosed with recurrent VVC (RVVC). Please keep an eye on our website or clinicaltrials.gov to monitor the progress of clinical trials that may begin in the future.